Genomic Screening for Targets Regulated by Berberine in Breast Cancer Cells |
Wen, Chun-Jie
(Institute of Life Sciences, Chongqing Medical University)
Wu, Lan-Xiang (Institute of Life Sciences, Chongqing Medical University) Fu, Li-Juan (Institute of Life Sciences, Chongqing Medical University) Yu, Jing (Institute of Clinical Pharmacology, Central South University) Zhang, Yi-Wen (Institute of Clinical Pharmacology, Central South University) Zhang, Xue (Institute of Life Sciences, Chongqing Medical University) Zhou, Hong-Hao (Institute of Life Sciences, Chongqing Medical University) |
1 | Koren R, Rocker D, Kotestiano O, Liberman UA, Ravid A (2000). Synergistic anticancer activity of 1,25-dihydroxyvitamin D3 and immune cytokines: the involvement of reactive oxygen species. J Steroid Biochem Mol Biol, 73, 105-12. DOI ScienceOn |
2 | Kuo CL, Chi CW, Liu TY (2005). Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo, 19, 247-52. |
3 | Lee YS, Kim WS, Kim KH, et al (2006). Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes, 55, 2256-64. DOI ScienceOn |
4 | Liu J, He CW, Zhou KY, Wang JD, Kang JX (2009). Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochem Biophys Res Commun, 378, 174-8. DOI ScienceOn |
5 | Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T).). Method. Methods, 25, 402-8. DOI ScienceOn |
6 | Okuno S, Sato H, Kuriyama-Matsumura K, et al (2003). Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer, 88, 951-6. DOI ScienceOn |
7 | Patil JB, Kim J, Jayaprakasha GK (2010). Berberine induces apoptosis in breast cancer cells (MCF-7). through mitochondrial-dependent pathway. Eur J Pharmacol, 645, 70-8. DOI ScienceOn |
8 | Sekhon BK, Roubin RH, Tan A, Chan WK, Sze DM (2008). High-throughput screening platform for anticancer therapeutic drug cytotoxicity. Assay Drug Dev Technol, 6, 711-21. DOI ScienceOn |
9 | Imanshahidi M, Hosseinzadeh H (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res, 22, 999-1012. DOI ScienceOn |
10 | Ahonen M, Ala-Aho R, Baker AH, et al (2002). Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3. Mol Ther, 5, 705-15. DOI ScienceOn |
11 | Balkwill F (2004). The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol, 14, 171-9. DOI ScienceOn |
12 | Chen L, Chen J, Xu H (2013). Sasanquasaponin from Camellia oleifera Abel. induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells. Fitoterapia, 84, 123-9. DOI ScienceOn |
13 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
14 | Kim JB, Lee KM, Ko E, et al (2008a). Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Plant Med, 74, 39-42. DOI ScienceOn |
15 | Kim S, Choi JH, Kim JB, et al (2008b). Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules, 13, 2975-85. DOI ScienceOn |
16 | Kim S, Han J, Lee SK, et al (2012). Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC- in breast cancer cells. J Surq Res, 176e, 21-9. |
17 | Tsuchiya Y, Nakajima M, Yokoi T (2005). Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett, 227, 115-24. DOI ScienceOn |
18 | Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK (2011). Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2 and prostaglandin E2 receptors. Carcinogenesis, 32, 86-92. DOI ScienceOn |
19 | Tan MJ, Teo ZQ, Sng MK, Zhu PC, Tan NS (2012). Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res, 10, 677-88. DOI ScienceOn |
20 | Tan YL, Goh D, Ong ES (2006). Investigation of differentially expressed proteins due to the inhibitory effects of berberine in human liver cancer cell line HepG2. Mol Biosyst, 2, 250-8. DOI ScienceOn |
21 | Wang W, Huper G, Guo Y, et al (2005). Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene, 24, 2705-14. DOI ScienceOn |
22 | Wu K, Yang Q, Mu Y, et al (2011). Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/-catenin signaling. Int J Oncol, 41, 292-8. |
23 | Tillhon M, Guaman Ortiz LM, Lombardi P, Scovassi AI (2012). Berberine: New perspectives for old remedies. Biochemical Pharmacology, 84, 1260-7. DOI ScienceOn |
24 | Meeran SM, Katiyar S, Katiyar SK (2008). Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol, 229, 33-43. DOI ScienceOn |